Drug development is expensive and failure is the norm. As a result, drug companies, investors and academic institutions are forced to make choices about how to spend money and time. Early on in ...
Digital Science investigations show researchers associated with a fictitious research network and funding source have netted millions of taxpayers' dollars in funding.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback